Patents Assigned to Governors of the University of Calgary
-
Patent number: 11374998Abstract: A processing system may determine, during a downloading of a first video chunk associated with a first time block of a video, a risk of stall condition, the first video chunk encoded at a first bitrate of a plurality of available bitrates, determine that a number of a received first plurality of frames of the first video chunk exceeds a threshold, transmit a request for a next video chunk associated with a next time block of the video and an indication to a source device to stop transmitting additional frames of the first video chunk, receive a second plurality of frames of the first video chunk from the source device that were transmitted prior to the source device receiving the indication, receive frames of the next video chunk, and play the first and second plurality of frames of the first video chunk, and the frames of the next video chunk.Type: GrantFiled: September 1, 2021Date of Patent: June 28, 2022Assignees: AT&T Intellectual Property I, L.P., The Governors of the University of CalgaryInventors: Emir Halepovic, Yang Liu, Mea Wang
-
Publication number: 20210299083Abstract: A method for treating a viral infection of a mammalian subject that comprises administering a virus-inhibiting amount of a halogenated xanthene, a pharmaceutically acceptable salt, an alkyl ester or amide or aromatic ester or amide derivative thereof as disclosed within, to that mammalian subject. A method of inducing a type I interferon response in a mammalian subject that presents with a microbial infection, cancerous tumor or hematological malignancy that comprises administering an amount of a halogenated xanthene as discussed above, effective to induce the type I interferon response. A method of enhancing a mammalian immunogen-specific immune response that comprises contacting mammalian cells, in vivo or present in a mammalian cell growth supporting medium, with an adjuvant-effective amount of a halogenated xanthene as discussed above, and an immunogen to which that response is to be enhanced.Type: ApplicationFiled: March 25, 2021Publication date: September 30, 2021Applicants: Provectus Pharmatech, Inc., Governors of the University of CalgaryInventors: Aru Narendran, Edward V. Pershing, Dominic Rodrigues, Bruce Horowitz, Eric A. Wachter
-
Publication number: 20210299055Abstract: The present invention contemplates a method of treating a solid cancerous tumor in a mammalian subject by the oral administration of a solid cancerous tumor-effective amount of a halogenated xanthene (HX), the lactone thereof, a pharmaceutically acceptable salt, or a C1-C4 alkyl or aromatic ester thereof (collectively an HX compound) to that mammalian subject, and liquid and solid pharmaceutical compositions for administering the HX compound. In addition, a method of inhibiting the growth of a GI tract carcinoma of a mammalian subject by the oral administration of a solid cancerous tumor-effective amount of an HX compound, as well as solid and liquid pharmaceutical compositions therefor.Type: ApplicationFiled: March 26, 2021Publication date: September 30, 2021Applicants: Provectus Pharmatech, Inc., Governors of the University of CalgaryInventors: Eric A. WACHTER, Dominic RODRIGUES, Edward V. PERSHING, Bruce HOROWITZ, Timothy C. SCOTT, H. Craig DEES, Aru NARENDRAN
-
Patent number: 10735744Abstract: Devices, computer-readable media, and methods for recording a video chunk in a designated order comprising a plurality of intra-frame coded frames followed by a plurality of inter-frame coded frames are disclosed. For instance, a processing system including at least one processor may obtain a video chunk associated with a time block of a video. In one example, the video chunk includes a plurality of frames encoded in a bitrate of a plurality of available bitrates for the time block of the video, and the plurality of frames includes a plurality of intra-frame coded frames and a plurality of inter-frame coded frames. In one example, the plurality of frames is in a first order. The processing system may then record the video chunk in a second order comprising the plurality of intra-frame coded frames followed by the plurality of inter-frame coded frames.Type: GrantFiled: October 22, 2018Date of Patent: August 4, 2020Assignees: AT&T Intellectual Property I, L.P., The Governors of the University of CalgaryInventors: Emir Halepovic, Cyriac James, Mea Wang
-
Publication number: 20180267020Abstract: Provided herein are methods of diagnosing and/or treating ACVS, by determining expression levels of several ACVS-related molecules, such as FABP3, ANPR-1, IGFBP-3, F9, SELL, apoB100, ADPN, vWF, THBS1, PRL, PON3, EGFR, VEGF-D, HPX, MBT, F5, F10, SERPIN A5, HCII, and HABP2, for example in a blood sample.Type: ApplicationFiled: March 19, 2018Publication date: September 20, 2018Applicants: UVic Industry Partnerships Inc., Vancouver Island Health Authority, British Columbia Center for Disease Control, The Governors of the University of CalgaryInventors: Andrew Penn, Christoph Hermann Borchers, Mary Louise Lesperance, Angela Marie Jackson, Maximilian Barnaby Bibok, Viera Saly, Robert Fred Balshaw, Shelagh Brown Coutts
-
Patent number: 4558301Abstract: A voltage-to-frequency and analog-to-digital conversion circuit using a microprocessor-controlled capacitor charge-discharge scheme provides high resolution and low component count and is particularly suitable for use with resistance bridge transducers.Type: GrantFiled: July 1, 1982Date of Patent: December 10, 1985Assignees: Trofimenkoff Engineering, Ltd., Jai Bhagwan, Sandro Poscente, Governors of the University of CalgaryInventors: Frederick N. Trofimenkoff, Jai Bhagwan, Sandro P. Poscente